Search Results - Royalty Tredo, Sarah

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial

    Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial by Bennett, Sean R, McCarty, James M, Ramanathan, Roshan, Mendy, Jason, Richardson, Jason S, Smith, Jonathan, Alexander, Jeff, Ledgerwood, Julie E, de Lame, Paul-André, Royalty Tredo, Sarah, Warfield, Kelly L, Bedell, Lisa

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individuals

    Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individuals by McCarty, James M., Bedell, Lisa, Mendy, Jason, Coates, Emily E., Chen, Grace L., Ledgerwood, Julie E., Tredo, Sarah Royalty, Warfield, Kelly L., Richardson, Jason S.

    Published in Vaccine
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    2888. Safety and Immunogenicity of an Adjuvanted Chikungunya Virus (CHIKV) Virus-like Particle (VLP) Based Vaccine in Two Pivotal Phase 3 Trials, ≥12 Years of Age

    2888. Safety and Immunogenicity of an Adjuvanted Chikungunya Virus (CHIKV) Virus-like Particle (VLP) Based Vaccine in Two Pivotal Phase 3 Trials, ≥12 Years of Age by Richardson, Jason S, Anderson, Debbie, Mendy, Jason, Muhammad, Sufia, Tindale, Lauren, Loreth, Tobi, Tredo, Sarah Royalty, Jenkins, Victoria, Ajiboye, Patrick, Bedell, Lisa

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: